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Background: Several European countries, including Belgium, still suffer from mild iodine deficiency. Thyroid
stimulating hormone (TSH) concentration in whole blood measured at birth has been proposed as an indicator of
maternal iodine status during the last trimester of pregnancy. It has been shown that mild iodine deficiency during
pregnancy may affect the neurodevelopment of the offspring. In several studies, elevated TSH levels at birth were
associated with suboptimal cognitive and psychomotor outcomes among young children. This paper describes the
protocol of the PSYCHOTSH study aiming to assess the association between neonatal TSH levels and intellectual,
psychomotor and psychosocial development of 4–5 year old children. The results could lead to a reassessment of
the recommended cut-off levels of 5 >mU/L used for monitoring iodine status of the population.
Methods: In total, 380 Belgian 4–5 year old preschool children from Brussels and Wallonia with a neonatal blood spot
TSH concentration between 0 and 15 mU/L are included in the study. For each sex and TSH-interval (0–1, 1–2, 2–3,
3–4, 4–5, 5–6, 6–7, 7–8, 8–9 and 9–15 mU/L), 19 newborns were randomly selected from all newborns screened by the
neonatal screening centre in Brussels in 2008–2009. Infants with congenital hypothyroidism, low birth weight and
prematurity were excluded from the study. Neonatal TSH concentration was measured by the Autodelphia method in
dried blood spots, collected by heel stick on filter paper 3 to 5 days after birth. Cognitive abilities and psychomotor
development are assessed using the Wechsler Preschool and Primary Scale of Intelligence - third edition - and the
Charlop-Atwell Scale of Motor coordination. Psychosocial development is measured using the Child Behaviour Check
List for age 1½ to 5 years old. In addition, several socioeconomic, parental and child confounding factors are assessed.
Conclusions: This study aims to clarify the effect of mild iodine deficiency during pregnancy on the neurodevelopment
of the offspring. Therefore, the results may have important implications for future public health recommendations,
policies and practices in food supplementation. In addition, the results may have implications for the use of neonatal TSH
screening results for monitoring the population iodine status and may lead to the definition of new TSH cut-offs for
determination of the severity of iodine status and for practical use in data reporting by neonatal screening centres.
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According to the World Health Organization (WHO),
iodine deficiency is the main cause of preventable brain
damage [1]. Iodine is important for the production of
thyroid hormones (TH), which are essential for the devel-
opment of the central nervous system [2]. Severe iodine
deficiency may lead to perinatal mortality and mental
retardation [3]. Maternal iodine deficiency during preg-
nancy, even at mild to moderate levels, may affect the
neurodevelopment of the offspring [4]. Median urinary
concentration is used to define classification of the levels
of iodine intake as shown in Table 1.
Iodine deficiency is defined through three levels of se-
verity: mild, moderate or severe. Severe iodine deficiency
has been observed mainly in Central Africa and Asia and
is considered to be disappeared in Europe. However, sev-
eral European countries, including Belgium, still suffer
from mild iodine deficiency (MID) despite implementa-
tion of salt iodization programmes as national measures
to supress iodine deficiency [5-8]. From 2003 to 2007, the
number of European countries which are mildly iodine
deficient decreased from 23 to 14 [9] showing that iodine
deficiency remains a problem in Europe. Iodine deficiency
even re-emerged in countries previously iodine sufficient
such as the UK [10]. With respect to Belgium, recent
studies found that school aged children were iodine suffi-
cient while women at childbearing age and pregnant
women had MID [7,8]. It is a matter of concern as MID
during pregnancy could lead to suboptimal cognitive and
psychomotor outcomes in the offspring [4].
Thyroid stimulating hormone (TSH) concentration in
whole blood measured at birth has been proposed as an
indicator of maternal iodine status during the last tri-
mester of pregnancy [11]. TSH controls and stimulates
the production of TH. In order to maintain circulating
TH levels within the required range, TSH is secreted. If
iodine stores are insufficient to produce TH, TSH con-
centration increases. Figure 1 illustrates the change in
neonatal TSH concentration in case of maternal iodine
sufficiency or deficiency during pregnancy.
Several studies showed that elevated TSH levels after
birth were associated with suboptimal cognitive andTable 1 Median UI in school aged children: indicator of
iodine nutrition
Median UI (μg/l) Iodine nutrition
<20 Severe iodine deficiency
20-49 Moderate iodine deficiency
50-99 Mild iodine deficiency
100-199 Iodine sufficiency
200-299 Iodine intake more than adequate
>300 Iodine excess
Source: WHO, 2004 [1].psychomotor outcomes [12-15]. Though, it is hard to
claim that the observed impairments in cognitive and/or
psychomotor functioning are a direct consequence of
MID during gestation. An elevated TSH level at birth can
be caused by several factors [16-27] and some of them
affect both TSH levels and IQ in childhood [14,23,28-59].
Further studies are needed to evaluate the association be-
tween elevated TSH at birth and intellectual, psychomotor
and psychosocial development of preschool children tak-
ing into account confounding factors.
In order to evaluate the efficiency of national pro-
grammes implemented to suppress iodine deficiency,
adapted surveillance of the iodine status of the population
is important. To monitor the iodine status of a population,
median urinary iodine excretion, thyroid size, neonatal
TSH concentration in blood and thyroglobulin concentra-
tion in blood can be used as indicators [60-63].
In most developed countries, neonatal screening pro-
grammes for congenital hypothyroidism are organised
allowing early detection and treatment of children with
thyroid hormone therapy [64]. When neonatal screening
programmes are set up in a country, the WHO recom-
mends the use of TSH results to monitor iodine status
in that population [60].
The percentage of neonatal TSH screening results
greater than 5 mU/L can be used to define the iodine sta-
tus of a population (see Table 2) as follows: a frequency
below 3% indicates iodine sufficiency, a frequency of 3–
19.9% indicates mild iodine deficiency, a frequency of 20–
39.9% indicates moderate deficiency and a frequency above
40% indicates iodine deficiency respectively [27,60,61].
In several studies, the neonatal TSH results have been
used to assess the iodine status of the population [65-68].
However the cut-off of 5 mU/L recommended by the
WHO has been criticized [69-71]. In addition, a percent-
age below 3% of the TSH results greater than 5 mU/L was
found in populations with MID [27,72] failing to detect
MID in those population. Since the proposed cut-off of
percentage of TSH screening results >5 mU/L below 3%
is not sensitive enough to detect MID, it should be
reassessed.Research objectives
The purpose of the PSYCHOTSH study is to assess the re-
lationship between neonatal TSH levels and intellectual,
psychomotor and psychosocial development of children
aged 4–5 years old. It is hypothesized that children with a
neonatal TSH level (at day 3 to 5) in the highest quintile,
used as marker of lower intrauterine iodine supply, have a
higher risk to develop psychomotor, cognitive as well as
behavioural problems. In addition, the study aims to
reassess the cut-off of 5 mU/L of neonatal TSH concen-
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Figure 1 Neonatal thyroid stimulating hormone concentration as indicator of maternal iodine deficiency. Legend: In the thyroid gland,
thyroid hormones (TH) T3 and T4 are produced from association of tyrosine and iodine. Liberation of thyroid stimulating hormones (TSH)
stimulates TH production and secretion. The lack of TH in the bloodstream leads to the liberation of thyrotropin-releasing hormone (TRH) from
the hypothalamus. TRH stimulates the liberation of TSH by the pituitary gland. A - In situation of maternal iodine sufficiency, iodine stocks are
sufficient to produce adapted amount of TH and TSH release is inhibited by negative feedback inhibition. B - In situation of maternal iodine
deficiency, iodine stocks are insufficient to produce adapted quantity of TH and TSH release is maintained leading to increased TSH concentration
in bloodstream.
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found between TSH level and children’s intellectual, psy-
chomotor and psychosocial development will be used to




The children were selected from the total sample of neo-
nates screened in 2008 and 2009 by the Brussels newborn
screening centre for metabolic disorders (Laboratoire deTable 2 Percentage of neonatal TSH screening results
>5 mU/L at screening: indicator of iodine nutrition
Percentage of neonatal TSH > 5 mU/L Iodine nutrition
0-3% Iodine sufficiency
3-19.9% Mild iodine deficiency
20 à 39,9% Moderate iodine deficiency
≥ 40% Severe iodine deficiency
Source: WHO, 1994 [60].Pédiatrie, Université Libre de Bruxelles, Brussels). Neonatal
TSH level was measured in dried blood spots on filter
paper collected by heel stick 3 to 5 days after birth. The
measurement of TSH was performed using a time-resolved
fluroimmunoassay (Autodelfia method) on filter paper [73].
Subjects
A sample size of 315 children was determined based on a
detection probability (or power) of 95%, a significance
level alpha of 5% and a correlation factor between TSH
and IQ of 0.2. An anticipated drop-out of 20% was taken
into account. 380 children aged 4–5 years old with a neo-
natal TSH concentration in the range 0–15 mU/L were
included in the study. Children were stratified by sex and
by TSH level using a stratified sampling methodology.
The details of the sample are shown in Table 3.
For each sex and TSH-interval (0–1, 1–2, 2–3, 3–4,
4–5, 5–6, 6–7, 7–8, 8–9 and 9–15 mU/L) 19 newborns
were selected randomly. In addition, the day of collec-
tion was taken into account. Exclusion criteria were: 1)
neonatal TSH level of 15 mU/L or higher as this is the
Table 3 Sample stratification of newborns by neonatal
TSH level and by sex
Neonatal TSH level mU/L Boys Girls Total
1-0 19 19 38
1-2 19 19 38
2-3 19 19 38
3-4 19 19 38
4-5 19 19 38
5-6 19 19 38
6-7 19 19 38
7-8 19 19 38
8-9 19 19 38
9-15 19 19 38
Total 190 190 380
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hypothyroidism, 2) prematurity (<37 weeks) and low
birth weight (<2500 g) as this may induce TSH elevation
at birth and alteration of neurodevelopment, 3) neuro-
logical disease of the children and 4) non-French speak-
ing children (in order to perform psychological testing
in the children’s mother tongue). For each selected
infant, 3 replacements (with same TSH level and sex)
were randomly selected, in case of refusals or non-
contactable individuals.
Approval by Ethical Committee for human subjects and
by Privacy Commission
A written informed consent is obtained from the parents
before the start of the procedure (i.e. home visit). The
study design, the data collection procedures, the consent
form and the invitation letter were approved by the Eth-
ical Committee of the Erasme hospital (Université Libre
de Bruxelles, Brussels) in accordance with the Code of
Ethics of the World Medical Association for experiments
involving humans (Declaration of Helsinki). The study
was also approved by the Belgian Privacy Commission.
Psychological testing
Psychometric assessment is done by 7 trained clinical
psychologists during a home visit. Psychologists are
blinded for the neonatal TSH levels of the selected chil-
dren. Before test administration, the parents are asked to
provide a quiet room and leave the psychologist alone
with the child. If the child does not feel comfortable be-
ing left alone with the psychologist, one adult may stay
in the room with the child, outside his or her field of
view and without interrupting the psychologist.
Cognitive development is assessed using age-appropriate
cognitive tests, the French version of the Wechsler Pre-
school and Primary Scale of Intelligence - third edition
(WPPSI-III) [74,75]. The WPPSI-III is a test administeredindividually and allows to measure intelligence of children
aged 2 years 6 months to 7 years 3 months; it is divided
into 2 age groups: 2 years 6 months to 3 years 11 months
old and 4 years to 7 years 3 months old. The test contains
14 subtests: 7 verbal tests, 5 performance tests and 2 pro-
cessing speed tests. These subtests allow calculating a full
scale Intelligence Quotient (IQ), a verbal IQ, a performance
IQ, a processing speed quotient and an optional score of
general language knowledge.
Psychomotor development is assessed using the French
adapted version of the Charlop-Atwell Scale of Motor
Coordination [76,77]. This individually administered test
evaluates gross motor coordination abilities of children of
3½ to 6 years old using 6 subtests. The scale contains a
subjective rating (based on quality of performance) in
addition to an objective subtest rating (based on accuracy
of performance).
Psychosocial development is evaluated using the French
version of the Child Behaviour Check List (CBCL) for ages
1½ to 5 years old [78]. This test allows obtaining 3 scores:
a total problem score, a score on internalizing problems
and a score on externalizing problems. Internalizing prob-
lems represent problems of the self, like withdrawal, anx-
iety or depression. Externalizing problems are problems
with others, problems of conflicts or problems with au-
thority, like aggressive behaviour or attention problems.
The total problem score includes these 2 scores plus a
score on sleeping problems and a score on “other prob-
lems”. In order to calculate the scores, the Windows Soft-
ware Assessment Data Manager is used [78].
Children anthropometric measurements
Next to psychometric assessment, the actual weight,
height and head circumference of the child are measured
using SECA 815 or SECA 804 weight scales, SECA 214
stadiometers and SECA 212 flexible measuring tapes.
Children urinary iodine concentration
A sample of urine is collected from the child during the
home visit. The aim is to determine the current iodine
status among the children included in the study. All
urine samples are frozen and kept at −80°C until ana-
lysis. Analyses of the samples are performed at the
Erasme Hospital. Urinary iodine excretion is measured
using a modification of the Sandelle-Kolthoff reaction
with spectrophotometric detection [79].
Data collection of covariates, effect modifiers and
descriptive variables
The variables collected in this study as covariates, effect
modifiers and descriptive variables are shown in Table 4.
Information about covariates and effect modifiers is
gathered from the data provided by the ULB newborn
screening centre for metabolic disorders. Additional
Table 4 Covariates, effects modifiers and descriptive variables of the PSYCHOTSH study
Covariates Effect modifiers Descriptive variables
Association of elevation of TSH and impaired Elevation of TSH Neurodevelopment and/or
psychometric testing
Neurodevelopment
Foetus in utero exposure to: Foetus in utero exposure to: Child related factor: Zip code of the house of the
child
Child bilinguism
Iodine excess Iodine containing drugs Chronic disease of the child Date of birth of the
TSH-receptor blocking antibodies from mothers
with autoimmune thyroid disease
Attending nursery school child, mother and father
Height and weight of the child
at birth




Actual height, weight of child,
mother and father
Child negative life events
Contrast agents Exposition to cold Parenting stress
Organochlorides Surgical hypothermia Dysfunctional parenting Head circumference of the
child
Lithium Delivery by forceps extraction
Cadmium Household composition
Maternal smoking TSH testing: Nationality and origin of the
child and the parents
Maternal alcohol consumption Timing of blood sampling
TSH assay used Parents related factors: Maternal/paternal education
and employment
Level of education Household incomes
Household incomes Marital status and custody
Maternal age at birth
Parity
Exposition of the new-born during neonatal
period:
Exposure to iodine-containing antiseptics Gravidity
Perinatal anoxia Pre-pregnancy body mass
index








Maternal poor social support
Marital discord
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birth and the home visit at 4–5 year old is collected using a
self-report questionnaire filled in by the mother and from
consultation of the health booklet of the child by the psych-
ologist. In addition, the name of the gynaecologist is re-
quested in the informed consent form in case additional
information will be needed regarding the health of the
mother during pregnancy.Concerning pregnancy the following data are col-
lected: exposure to iodine excess (use of iodine- con-
taining antiseptics), intake of iodine-containing drugs,
exposure to organochlorides, exposure to cadmium,
lithium intake, thyroid disease of the mother, anti-
thyroid drug intake, diabetes and treatment of diabetes,
alcohol consumption and cigarette smoking, maternal
age at birth, reproductive history, parity, gravidity, pre-
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http://www.archpublichealth.com/content/72/1/27pregnancy body mass index (BMI), weight gain of the
mother during pregnancy.
Concerning the neonatal period the following data are
collected: exposure to iodine excess (use of iodine-
containing antiseptics), health problems of the newborn,
type of delivery, season of birth and perinatal anoxia.
Concerning the period between birth and the home
visit the following information is gathered about the
parents: maternal/paternal education and employment,
household income, marital status, area of residence, ma-
ternal age and information about housing.
Concerning the period between birth and the home
visit the following information is gathered about the
child: breastfeeding, chronic disease, attending nursery
school, bilingualism, previous intellectual assessment.
In addition a self-report questionnaire is used to assess
several psychological factors supposed to influence men-
tal development: child’s negative life events, maternal
mental health, maternal social support, marital discord
and parent–child interactions. Some of the questions
were adapted from existing questionnaires [80-83].
Discussion and conclusion
Several studies showed that elevated TSH levels after
birth were associated with suboptimal cognitive and
psychomotor outcomes [12-15]. However, many factors
may influence neonatal TSH [16-27] concentration and
some of them may affect both TSH levels and neurodeve-
lopment in childhood [14,23,28-59]. The present study
aims to evaluate association between elevated TSH at
birth and intellectual, psychomotor and psychosocial
development of preschool children taking into account
confounding factors. This study aims to clarify the effect
of MID during pregnancy on the neurodevelopment of
the offspring. Therefore, the results may have important
implications for future public health recommendations,
policies and practices in food supplementation.
In order to evaluate the efficiency of national pro-
grammes implemented to suppress iodine deficiency,
adapted surveillance of the iodine status of the population
is needed. To monitor the iodine status of a population,
neonatal TSH whole blood concentration can be used as
an indicator [60]. The proposed cut-off percentage below
3% of the TSH results >5 mU/L was shown to be not sen-
sitive enough to detect MID [27,72]. The present study
aims to reassess the recommended cut-off of >5 mU/L
using ROC curve analysis. Therefore, the results of the
study could help to clarify the potential use of neonatal
TSH screening results for monitoring the iodine status of
populations. Furthermore, the results could lead to the
definition of a new neonatal TSH cut-off for monitoring
the iodine status of populations. The results could also
have an impact on the definition of the cut-off of TSH
levels used for reporting by neonatal screening centres.Abbreviations
MID: Mild iodine deficiency; ROC: Receiver operating characteristic;
TH: Thyroid hormone; TRH: Thyrotropin-releasing hormone; TSH:
Thyroid-stimulating hormone; WHO: World Health Organization.
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